EGFR TARGETED THERAP... 申请号：JP2018197322 专利类型：发明申请 公开（公告）日：2018-10-19
状态：寻求转化 转让价格：面议
PROBLEM TO BE SOLVED : To provide compositions and methods for treatment of neurological disorders, in particular, an epidermal growth factor receptor (EGFR) as a clinical target for treatment of n...
EGCG在制备预防和/或治疗PRV感染制... 申请号：CN201911022059.X 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
本发明提供了表没食子儿茶酚没食子酸酯在制备预防和/或治疗猪伪狂犬病毒感染制剂中的应用和预防和/或治疗猪伪狂犬病毒的制剂，属于猪伪狂犬病毒感染治疗技术领域，所述药物中表没食子儿茶酚没食子酸酯的浓度为10～100μmol/L。本发明中，所述表没食子儿茶酚没食子酸酯抗猪伪狂犬病毒感染效果非常显著：所述表没食子儿茶酚没食子酸酯可以减少猪伪狂犬病毒引起的细胞病变，抑制猪伪狂犬病毒的吸附、入胞和复制，且可直接...
EGCG在制备预防和/或治疗PRV感染制... 申请号：CN201911022059.X 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
本发明提供了表没食子儿茶酚没食子酸酯在制备预防和/或治疗猪伪狂犬病毒感染制剂中的应用和预防和/或治疗猪伪狂犬病毒的制剂，属于猪伪狂犬病毒感染治疗技术领域，所述药物中表没食子儿茶酚没食子酸酯的浓度为10～100μmol/L。本发明中，所述表没食子儿茶酚没食子酸酯抗猪伪狂犬病毒感染效果非常显著：所述表没食子儿茶酚没食子酸酯可以减少猪伪狂犬病毒引起的细胞病变，抑制猪伪狂犬病毒的吸附、入胞和复制，且可直接...
EFLORNITHINE AND SUL... 申请号：US15771484 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methods ...
EFLORNITHINE AND SUL... 申请号：US15771484 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
Provided herein are fixed-dose combination formulations of a pharmaceutically effective amount of eflornithine together with a pharmaceutically effective amount of sulindac. Also provided are methods ...
EFFICIENT USAGE OF S... 申请号：US13959690 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
Exemplary embodiments provide a computer implemented method and computer program product for efficient usage of screen real estate, and an electronic device configured to execute the computer program...
EFFECT OF COMBINATIO... 申请号：WOCN19096102 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
Disclosed is the use of bifidobacterium and berberine in the preparation of a drug for treating pre-diabetes or type 2 diabetes. Specifically, it is suitable for pre-diabetes patients or type 2 diabe...
EFFECT OF COMBINATIO... 申请号：WOCN19096102 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
Disclosed is the use of bifidobacterium and berberine in the preparation of a drug for treating pre-diabetes or type 2 diabetes. Specifically, it is suitable for pre-diabetes patients or type 2 diabe...
EDIBLE PIGMENT COMPO... 申请号：JP2017185550 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
To provide an edible pigment composition that has a small average dispersion particle size of a pigment and excellent dispersibility, and is applied to an inkjet aqueous ink composition, to allow di...
ECTOPICALLY EXPRESSE... 申请号：WOEP18086782 专利类型：发明申请 公开（公告）日：
状态：寻求转化 转让价格：面议
The present invention relates to a nucleic acid construct allowing to drives the expression of a transcription factor in rod cells or cone cells thereby silencing the expression of a gene which mutate...
